[A review of 72 renal artery stenoses in a series of 715 kidney transplantations in children]

Prog Urol. 1994 Apr;4(2):193-205.
[Article in French]

Abstract

In a series of 715 renal transplantations performed between 1973 and 1989, 72 cases of renal artery stenosis (RAS) in 69 children (9.7%) were managed at Hôpital Necker Enfants Malades. Forty cases of RAS were treated exclusively by antihypertensive drugs. A good result was obtained in 82.5% of cases. Thirty three transluminal angioplasties (TLA) were performed in 23 children with 26 RAS. A good clinical result was obtained in 15 children with a total of 17 stenoses, corresponding to a success rate of 65%. Transluminal dilatation of anastomotic stenoses always failed. There were no cases of transplant thrombosis. Eleven RAS were operated, including 5 after failure of TLA. Eight patients (73%) obtained a clinical improvement. There were 2 postoperative thromboses. Antihypertensive treatment must be administered in every case. If medical treatment fails, and with the exception of anastomotic stenoses, TLA should be the first-line procedure, while surgery is reserved for failures of TLA and for anastomotic stenoses.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Anastomosis, Surgical
  • Angioplasty, Balloon
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Brain Death
  • Child
  • Child, Preschool
  • Graft Survival
  • Humans
  • Hypertension / etiology
  • Infant
  • Kidney Transplantation*
  • Recurrence
  • Renal Artery Obstruction / complications
  • Renal Artery Obstruction / drug therapy
  • Renal Artery Obstruction / surgery
  • Renal Artery Obstruction / therapy*
  • Survival Rate
  • Thrombosis / complications
  • Thrombosis / drug therapy
  • Thrombosis / surgery
  • Thrombosis / therapy
  • Tissue Donors

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents